Inhibition of adipogenesis by oligonol through Akt-mTOR inhibition in 3T3-L1 adipocytes

Jae Yeo Park, Younghwa Kim, Jee Ae Im, Seungkwon You, Hyangkyu Lee

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Polyphenols have recently become an important focus of study in obesity research. Oligonol is an oligomerized polyphenol, typically comprised of catechin-type polyphenols from a variety of fruits, which has been found to exhibit better bioavailability and bioreactivity than natural polyphenol compounds. Here, we demonstrated that Oligonol inhibits 3T3-L1 adipocyte differentiation by reducing adipogenic gene expression. During adipogenesis, Oligonol downregulated the mRNA levels of peroxisome proliferator-activated receptor γ (PPARγ), CCAAT/enhancer binding proteins (C/EBP), and δ (C/EBPδ) in a dose-dependent manner and the expression of genes involved in lipid biosynthesis. The antiadipogenic effect of Oligonol appears to originate from its ability to inhibit the Akt and mammalian target of rapamycin (mTOR) signaling pathway by diminishing the phosphorylation of ribosomal protein S6 kinase (p70S6K), a downstream target of mTOR and forkhead box protein O1 (Foxo1). These results suggest that Oligonol may be a potent regulator of obesity by repressing major adipogenic genes through inhibition of the Akt signaling pathway, which induces the inhibition of lipid accumulation, ultimately inhibiting adipogenesis.

Original languageEnglish
Article number895272
JournalEvidence-based Complementary and Alternative Medicine
Volume2014
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Adipogenesis
Sirolimus
Adipocytes
Polyphenols
CCAAT-Enhancer-Binding Proteins
Obesity
Ribosomal Protein S6 Kinases
70-kDa Ribosomal Protein S6 Kinases
Lipids
Gene Expression
Peroxisome Proliferator-Activated Receptors
Catechin
Biological Availability
Fruit
Down-Regulation
Phosphorylation
oligonol
Messenger RNA
Research
Genes

All Science Journal Classification (ASJC) codes

  • Complementary and alternative medicine

Cite this

@article{dc3c8ab164ac4898a0d708c26ad7f645,
title = "Inhibition of adipogenesis by oligonol through Akt-mTOR inhibition in 3T3-L1 adipocytes",
abstract = "Polyphenols have recently become an important focus of study in obesity research. Oligonol is an oligomerized polyphenol, typically comprised of catechin-type polyphenols from a variety of fruits, which has been found to exhibit better bioavailability and bioreactivity than natural polyphenol compounds. Here, we demonstrated that Oligonol inhibits 3T3-L1 adipocyte differentiation by reducing adipogenic gene expression. During adipogenesis, Oligonol downregulated the mRNA levels of peroxisome proliferator-activated receptor γ (PPARγ), CCAAT/enhancer binding proteins (C/EBP), and δ (C/EBPδ) in a dose-dependent manner and the expression of genes involved in lipid biosynthesis. The antiadipogenic effect of Oligonol appears to originate from its ability to inhibit the Akt and mammalian target of rapamycin (mTOR) signaling pathway by diminishing the phosphorylation of ribosomal protein S6 kinase (p70S6K), a downstream target of mTOR and forkhead box protein O1 (Foxo1). These results suggest that Oligonol may be a potent regulator of obesity by repressing major adipogenic genes through inhibition of the Akt signaling pathway, which induces the inhibition of lipid accumulation, ultimately inhibiting adipogenesis.",
author = "Park, {Jae Yeo} and Younghwa Kim and Im, {Jee Ae} and Seungkwon You and Hyangkyu Lee",
year = "2014",
month = "1",
day = "1",
doi = "10.1155/2014/895272",
language = "English",
volume = "2014",
journal = "Evidence-based Complementary and Alternative Medicine",
issn = "1741-427X",
publisher = "Hindawi Publishing Corporation",

}

Inhibition of adipogenesis by oligonol through Akt-mTOR inhibition in 3T3-L1 adipocytes. / Park, Jae Yeo; Kim, Younghwa; Im, Jee Ae; You, Seungkwon; Lee, Hyangkyu.

In: Evidence-based Complementary and Alternative Medicine, Vol. 2014, 895272, 01.01.2014.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inhibition of adipogenesis by oligonol through Akt-mTOR inhibition in 3T3-L1 adipocytes

AU - Park, Jae Yeo

AU - Kim, Younghwa

AU - Im, Jee Ae

AU - You, Seungkwon

AU - Lee, Hyangkyu

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Polyphenols have recently become an important focus of study in obesity research. Oligonol is an oligomerized polyphenol, typically comprised of catechin-type polyphenols from a variety of fruits, which has been found to exhibit better bioavailability and bioreactivity than natural polyphenol compounds. Here, we demonstrated that Oligonol inhibits 3T3-L1 adipocyte differentiation by reducing adipogenic gene expression. During adipogenesis, Oligonol downregulated the mRNA levels of peroxisome proliferator-activated receptor γ (PPARγ), CCAAT/enhancer binding proteins (C/EBP), and δ (C/EBPδ) in a dose-dependent manner and the expression of genes involved in lipid biosynthesis. The antiadipogenic effect of Oligonol appears to originate from its ability to inhibit the Akt and mammalian target of rapamycin (mTOR) signaling pathway by diminishing the phosphorylation of ribosomal protein S6 kinase (p70S6K), a downstream target of mTOR and forkhead box protein O1 (Foxo1). These results suggest that Oligonol may be a potent regulator of obesity by repressing major adipogenic genes through inhibition of the Akt signaling pathway, which induces the inhibition of lipid accumulation, ultimately inhibiting adipogenesis.

AB - Polyphenols have recently become an important focus of study in obesity research. Oligonol is an oligomerized polyphenol, typically comprised of catechin-type polyphenols from a variety of fruits, which has been found to exhibit better bioavailability and bioreactivity than natural polyphenol compounds. Here, we demonstrated that Oligonol inhibits 3T3-L1 adipocyte differentiation by reducing adipogenic gene expression. During adipogenesis, Oligonol downregulated the mRNA levels of peroxisome proliferator-activated receptor γ (PPARγ), CCAAT/enhancer binding proteins (C/EBP), and δ (C/EBPδ) in a dose-dependent manner and the expression of genes involved in lipid biosynthesis. The antiadipogenic effect of Oligonol appears to originate from its ability to inhibit the Akt and mammalian target of rapamycin (mTOR) signaling pathway by diminishing the phosphorylation of ribosomal protein S6 kinase (p70S6K), a downstream target of mTOR and forkhead box protein O1 (Foxo1). These results suggest that Oligonol may be a potent regulator of obesity by repressing major adipogenic genes through inhibition of the Akt signaling pathway, which induces the inhibition of lipid accumulation, ultimately inhibiting adipogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84934778030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934778030&partnerID=8YFLogxK

U2 - 10.1155/2014/895272

DO - 10.1155/2014/895272

M3 - Article

VL - 2014

JO - Evidence-based Complementary and Alternative Medicine

JF - Evidence-based Complementary and Alternative Medicine

SN - 1741-427X

M1 - 895272

ER -